CRISPR Therapeutics AG (CRSP) Dips More Than Broader Market: What You Should Know [Yahoo! Finance]
CRISPR Therapeutics AG - Common Shares (CRSP)
Last crispr therapeutics ag - common shares earnings: 8/7 05:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
nasdaq.com/symbol/crsp/real-time
Company Research
Source: Yahoo! Finance
The stock's performance was behind the S&P 500's daily loss of 0.04%. Elsewhere, the Dow saw a downswing of 0.57%, while the tech-heavy Nasdaq appreciated by 0.04%. Shares of the company have appreciated by 9.44% over the course of the past month, outperforming the Medical sector's loss of 0.72%, and lagging the S&P 500's gain of 12.24%. The upcoming earnings release of CRISPR Therapeutics AG will be of great interest to investors. The company's upcoming EPS is projected at -$1.14, signifying a 27.85% increase compared to the same quarter of the previous year. Simultaneously, our latest consensus estimate expects the revenue to be $8.39 million, showing a 864.14% escalation compared to the year-ago quarter. CRSP's full-year Zacks Consensus Estimates are calling for earnings of -$4.93 per share and revenue of $35.78 million. These results would represent year-over-year changes of +23.8% and +919.38%, respectively. Investors should also take note of any recent adjustments to ana
Show less
Read more
Impact Snapshot
Event Time:
CRSP
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CRSP alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CRSP alerts
High impacting CRISPR Therapeutics AG - Common Shares news events
Weekly update
A roundup of the hottest topics
CRSP
News
- 3 Growth Stocks That Could Generate 10X Returns [Yahoo! Finance]Yahoo! Finance
- CRISPR Therapeutics AG (CRSP) Rises Higher Than Market: Key Facts [Yahoo! Finance]Yahoo! Finance
- CRISPR Therapeutics (CRSP) had its "sell (d-)" rating reaffirmed by <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a>.MarketBeat
- CRISPR Therapeutics Has Major Catalysts Ahead. Is This Biotech Stock a Screaming Buy? [Yahoo! Finance]Yahoo! Finance
- CRISPR Therapeutics Has Major Catalysts Ahead. Is This Biotech Stock a Screaming Buy? [Globe and Mail, The (Toronto, Canada)]Globe and Mail, The
CRSP
Earnings
- 2/12/26 - Miss
CRSP
Sec Filings
- 4/21/26 - Form ARS
- 4/21/26 - Form DEFA14A
- 4/21/26 - Form DEF
- CRSP's page on the SEC website